This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC 2022 Programme

Subpage Hero

.

Loading

Evidence-based GLP-1 RA clinical considerations and their relative attributes

14 May 2022
Keynote

 

 

 

 

An in-depth look at the GLP-1 RA class and how they compare with respect to the clinical considerations of people living with type 2 diabetes

This is a promotional symposium sponsored by Lilly. Please note this session is not eligible for accreditation.
Intended for UK Healthcare Professionals.

Relevant prescribing information and adverse event reporting can be found within the symposium presentation and on the Lilly stand.

 

Chairperson
Hannah Beba, Consultant Pharmacist: Diabetes (pending credentialing) - NHS Leeds CCG embedded in the Leeds GP Confederation
Speakers
Jonathan Rachman, Medical Associate VP - Eli Lilly

Partners

Lead Education Partner

  • CPPE
  • Morph

 

Education Partner

  • APTUK
  • BOPA
  • BPNG
  • CMHP
  • Health Education England

 

Education Partner

  • HIVPA
  • UKRPG
  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC

 

Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS

 

Education Partner

  • Soar Beyond
  • NHCA
  • UKBPA
  • UKCPA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS

 

Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber

 

Nominated Charity

  • Pharmacist Support

 

Newsletter Sign Up